Granahan Investment Management’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-241,853
| Closed | -$128K | – | 200 |
|
|
2019
Q4 | $128K | Buy |
241,853
+1,082
| +0.4% | +$573 | 0.01% | 181 |
|
|
2019
Q3 | $917K | Buy |
240,771
+18,200
| +8% | +$69.3K | 0.05% | 160 |
|
|
2019
Q2 | $1.48M | Sell |
222,571
-6,459
| -3% | -$43K | 0.07% | 157 |
|
|
2019
Q1 | $813K | Buy |
229,030
+166,831
| +268% | +$592K | 0.04% | 176 |
|
|
2018
Q4 | $247K | Sell |
62,199
-1,113
| -2% | -$4.42K | 0.02% | 187 |
|
|
2018
Q3 | $1.25M | Buy |
63,312
+2,474
| +4% | +$48.8K | 0.07% | 176 |
|
|
2018
Q2 | $1.93M | Buy |
+60,838
| New | +$1.93M | 0.12% | 165 |
|